Litcius/Paper detail

A novel bispecific chimeric PD1-DAP10/NKG2D receptor augments NK92-cell therapy efficacy for human gastric cancer SGC-7901 cell

Mingfeng Li, Lingtong Zhi, Meichen Yin, Changjiang Guo, Huiyong Zhang, Chengui Lu, Wuling Zhu

2020Biochemical and Biophysical Research Communications23 citationsDOI

Topics & Concepts

NKG2DChimeric antigen receptorCancer researchEctodomainImmunotherapyCytotoxic T cellCancer immunotherapyCell therapyCancer cellCellReceptorChemistryCancerMedicineInternal medicineBiochemistryIn vitroImmune Cell Function and InteractionCAR-T cell therapy researchT-cell and B-cell Immunology